You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LMWH

Showing 1 - 25 of 465
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intravenous Continuous LMWH Seems to be Safe Alternative to UFH

Completed
  • Refractory Respiratory Failure
  • No intervention, just retrospective analysis of data.
  • Prague, Czechia
    Unoversity Hospital Motol, Department of Anaesthesiology and Int
Aug 22, 2023

BMD and Ca-P Metabolism in RSA Patients: LMWH Use Versus Control

Recruiting
  • Recurrent Spontaneous Abortion
  • Low molecular weight heparin
  • Shanghai, Shanghai, China
    Renji Hospital, Shanghai Jiaotong University School of Medicine
May 18, 2023

Venous Thromboembolism Trial in Toronto (Prophylactic low molecular weight heparin, Low molecular weight heparin and low-dose

Recruiting
  • Venous Thromboembolism
  • Prophylactic low molecular weight heparin
  • Low molecular weight heparin and low-dose aspirin
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Jan 18, 2023

Rivaroxaban Versus Low-molecular-weight Heparin and

Completed
  • Venous Thromboembolism
  • Rivaroxaban (Xarelto, BAY 59-7939)
  • LMWH and Phenprocoumon
  • Multiple Locations, Germany
    Multiple facilities
Apr 27, 2022

Intracranial Hemorrhage in Glioma Venous Thromboembolism

Terminated
  • Glioma, Malignant
  • Observation of ICH and VTE
  • Sacramento, California
  • +1 more
Aug 5, 2022

Anticoagulation in Venous Thromboembolism and Cancer

Active, not recruiting
  • Neoplasms
  • Embolism
  • London, United Kingdom
    Pfizer Investigational Site
Nov 17, 2022

Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma Trial in Boston (Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe)

Enrolling by invitation
  • Sarcoma
  • +6 more
  • Aspirin 325mg
  • Enoxaparin 40Mg/0.4mL Prefilled Syringe
  • Boston, Massachusetts
    Santiago Lozano-Calderon
Jan 20, 2023

COVID-19 Trial in Melbourne, Brasschaat, Johannesburg (Enoxaparin)

Terminated
  • COVID-19
  • Melbourne, Australia
  • +2 more
Apr 26, 2022

Compare Health Care Costs Between Apixaban and Low Molecular

Active, not recruiting
  • Thromboembolism
    • New York, New York
      Pfizer Investigational
    Dec 1, 2022

    The Clinical Features and Pregnancy Outcomes of CTD Patients

    Recruiting
    • Connective Tissue Diseases
    • Pregnancy Related
    • Jinan, Shandong, China
      Qilu Hospital
    Sep 26, 2022

    Cushing Disease, DVT, Pulmonary Embolism Trial in China (LMWH/Rivaroxaban, IPC)

    Recruiting
    • Cushing Disease
    • +2 more
    • Guangzhou, Guangdong, China
    • +3 more
    Jul 10, 2022

    Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)

    Completed
    Has Results
    • Sars-CoV2
    • COVID
    • Newark, New Jersey
    • +5 more
    Nov 17, 2021

    Cancer Associated Thrombosis for Rivaroxaban - United States

    Completed
    • Treatment of Venous Thromboembolism in Cancer Patients
    • Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +2 more
    • Multiple Locations, Connecticut
      Many Locations
    May 18, 2022

    Is Anti-Factor Xa Associated With Outcome in Critical COVID-19

    Completed
    • Covid19
    • +2 more
    • The effect of LMWH
    • Monitoring frequency of aFXa-levels
    • Stockholm, Sweden
      Södersjukhuset
    Feb 24, 2022

    Gather Information About Rivaroxaban in United Kingdom Who Have

    Completed
    • Treatment of Venous Thromboembolism in Cancer Patients
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +2 more
    • Multiple Locations, United Kingdom
      Many locations
    Sep 19, 2022

    Gather Information About Rivaroxaban in Sweden With Cancer Who

    Active, not recruiting
    • Treatment of Venous Thromboembolism in Cancer Patients
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +3 more
    • Multiple Locations, Many Locations, Sweden
      Swedish registries
    Aug 18, 2022

    Venous Thromboembolism Trial (Peak value anti-Xa, Trough value anti-Xa, Control Group)

    Not yet recruiting
    • Venous Thromboembolism
    • Peak value anti-Xa
    • +2 more
    • (no location specified)
    May 15, 2022

    Covid19 Trial in Germany (Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or

    Recruiting
    • Covid19
    • Anticoagulation Agents (Edoxaban and/or high dose LMWH)
    • Low dose Low molecular weight heparin or Placebo
    • Aachen, Germany
    • +9 more
    May 16, 2022

    Deep-Venous Thrombosis Trial in Leiden (IPD Device delivered by Converis, Fraxiparine)

    Recruiting
    • Deep-Venous Thrombosis
    • Leiden, Zuid Holland, Netherlands
      Leiden University Medical Centre
    Apr 6, 2022

    Recurrent Pregnancy Loss Trial (Hydroxychloroquine)

    Not yet recruiting
    • Recurrent Pregnancy Loss
    • (no location specified)
    Feb 9, 2022

    LMWH Compliance in Pregnancy

    Recruiting
    • Venous Thromboembolism
    • Antenatal Deep Vein Thrombosis
    • Smart sharps bin - collects data on compliance
    • Cork, Ireland
      Cork University Maternity Hospital
    Sep 23, 2021

    Pregnancy, High Risk, Anticoagulants Trial in Orange (Lovenox)

    Recruiting
    • Pregnancy, High Risk
    • Anticoagulants
    • Orange, California
      University of California Irvine
    Apr 22, 2021

    Caprini Score in Venous Surgery: a Prospective Cohort Study

    Recruiting
    • Venous Thromboembolism
    • Varicose Veins
    • EVLT
    • +7 more
    • Moscow, Russian Federation
      Pirogov Russian National Research Medical University
    Feb 14, 2022

    Pulmonary Embolism, Thoracic Surgery Trial in Shanghai (Chemoprophylaxis with Low Molecular Weight Heparin (LMWH))

    Completed
    Has Results
    • Pulmonary Embolism
    • Thoracic Surgery
    • Chemoprophylaxis with Low Molecular Weight Heparin (LMWH)
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 5, 2021

    Thrombosis Trial in Worldwide (Apixaban, Vitamin K Antagonist (VKA), Low Molecular Weight Heparin (LMWH))

    Completed
    Has Results
    • Thrombosis
    • Phoenix, Arizona
    • +45 more
    Sep 29, 2022